Abstract B071: Monitoring the evolution of treatment resistance by transcriptional profiling of circulating tumor cells with RNAseqJamie M. Sperger, Joshua M. Lang, Xiao X. Wei et al.|Cancer Research|2026Cited by 0
Abstract B023: Identifying therapeutic vulnerabilities in metastatic prostate cancer transcriptional phenotypesDavid A. Gallo, Marina N. Sharifi, Jamie M. Sperger et al.|Cancer Research|2026Cited by 0
Abstract B073: Circulating Tumor Cell (CTC) single cell protein quantification reveals inter-patient heterogeneity in PSMA expression associated with LuPSMA response in a Metastatic Castration Resistant Prostate Cancer (mCRPC) patient cohortWilliam M. Stump, Marina N. Sharifi, Alex H. Chang et al.|Cancer Research|2026Cited by 0
Combining PSMA-PET metrics and circulating tumor cell RNA sequencing to predict LuPSMA response.Kendra D. Marr, Joshua M. Lang, Muhammad Mawiya Dar et al.|Journal of Clinical Oncology|2026Cited by 0